| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5ad8562c578b061df7a2c3aee9d0e24 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2400-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2570-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5038
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57419
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5044 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate |
2018-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10044b98362834b3583a0742146b9bb2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0234c0171b1a5920dc25ce3586210e57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f43cd4343c4a8feb343e7b5e5b96939f |
| publicationDate |
2020-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20200049200-A |
| titleOfInvention |
Method, composition and kit for screening ALK or ROS-1 kinase inhibitor |
| abstract |
Disclosed herein are methods, compositions and kits for ALK or ROS-1 phosphatase inhibitor screening. In one aspect, quantitative and qualitative analysis can be performed simultaneously, and screening for a larger and faster candidate substance is possible compared to a conventional molecular biological experiment method, and multiple ALK or ROS-1 phosphatase inhibitor candidate substances Since it is possible to grasp the level of change in cell lines using different metabolites as a whole, it has excellent screening efficiency for drugs that exhibit the inhibitory effect of ALK or ROS-1 phosphatase. Accordingly, the present invention has the advantage that it can be used in various ways in the development of new drugs showing the inhibitory effect of ALK or ROS-1 phosphatase. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220057286-A |
| priorityDate |
2018-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |